Allin M., Walshe M., Fern A., Nosarti C., Cuddy M., Rifkin L. et al. (2008) Cognitive maturation in preterm and term born adolescents. Journal of Neurology, Neurosurgery, and Psychiatry 79, 381–386.
Back S.A., Luo N.L., Borenstein N.S., Levine J.M., Volpe J.J. and Kinney H.C. (2001) Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. Journal of Neuroscience 21, 1302–1312.
Bakiri Y., Hamilton N.B., Karadottir R. and Attwell D. (2008) Testing NMDA receptor block as a therapeutic strategy for reducing ischaemic damage to CNS white matter. Glia 56, 233–240.
Bakiri Y., Burzomato V., Frugier G., Hamilton N.B., Karadottir R. and Attwell D. (2009) Glutamatergic signaling in the brain's white matter. Neuroscience 158, 266–274.
Deng W., Wang H., Rosenberg P.A., Volpe J.J. and Jensen F.E. (2004) Role of metabotropic glutamate receptors in oligodendrocyte excitotoxicity and oxidative stress. Proceedings of the National Academy of Sciences of the U.S.A. 101, 7751–7756.
Fern R. and Moller T. (2000) Rapid ischaemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. Journal of Neuroscience 20, 34–42.
Follett P.L., Rosenberg P.A., Volpe J.J. and Jensen F.E. (2000) NBQX attenuates excitotoxic injury in developing white matter. Journal of Neuroscience 20, 9235–9241.
Holopainen I.E. and Lauren H.B. (2011) Glutamate signaling in the pathophysiology and therapy of prenatal insults. Pharmacology Biochemistry and Behavior Epub ahead of print DOI: 10.1016/j.pbb.2011.03.016.
Jantzie L.L., Talos D.M., Selip D.B., An L., Jackson M.C., Folkerth R.D. et al. (xx) Developmental regulation of group I metabotropic glutamate receptors in the premature brain and their protective role in a rodent model of periventricular leukomalacia. Neuron Glia Biology xx, xxx (this issue).
Karadottir R., Cavelier P., Bergersen L.H. and Attwell D. (2005) NMDA receptors are expressed in oligodendrocytes and activated in ischaemia. Nature 4438, 1162–1166.
Kelland E.E. and Toms N.J. (2001) Group I metabotropic glutamate receptors limit AMPA receptor-mediated oligodendrocyte progenitor cell death. European Journal of Pharmacology 424, R3–R4.
Kobaly K., Schluchter M., Minich N., Friedman H., Taylor H.G., Wilson-Costello D. et al. (2008) Outcomes of extremely low birth weight (<1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003 < 1 kg) and extremely low gestational age (<28 weeks) infants with bronchopulmonary dysplasia: effects of practice changes in 2000 to 2003. Pediatrics 121, 73–81.
Li S. and Stys P.K. (2000) Mechanisms of ionotropic glutamate receptor-mediated excitotoxicity in isolates spinal cord white matter. Journal of Neuroscience 20, 1190–1198.
Luyt K., Váradi A., Durant C.E. and Molnár E. (2006) Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in prevention of apoptosis. Journal of Neurochemistry 99, 641–656.
Manning S.M., Talos D.M., Zhou C., Selip D.B., Park H.K., Park C.J. et al. (2008) NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia. Journal of Neuroscience 28, 6670–6678.
Martin J.A., Kung H.C., Mathews T.J., Hoyert D.L., Strobino D.M., Guyer B. et al. (2008) Annual summary of vital statistics: 2006. Pediatrics 121, 788–801.
Matute C. (2011) Glutamate and ATP signalling in white matter pathology. Journal of Anatomy, 219, 53–64.
Matute C., Sanchez-Gomez M.V., Martinez-Millan L. and Miledi R. (1997) Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. Proceedings of the National Academy of Sciences of the U.S.A. 94, 8830–8835.
McDonald J.W., Althomsons S.P., Hyrc K.L., Choi D.W. and Goldberg M.P. (1998) Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor – mediated excitotoxicity. Nature Medicine 4, 291–297.
Micu I., Jiang Q., Coderre E., Ridsdale A., Zhang L., Woulfe J. et al. (2006) NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia. Nature 439, 988–992.
Salter M.G. and Fern R. (2005) NMDA receptors are expressed in developing oligodendrocyte processes and mediate injury. Nature 438, 1167–1171.
Tekkok S.B. and Goldberg M.P. (2001) AMPA/kainate receptor activation mediates hypoxic oligodendrocyte death and axonal injury in cerebral white matter. Journal of Neuroscience 21, 4237–4248.
Volpe J.J. (2009) Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances. Lancet Neurology 8, 110–124.
Wake H., Lee P.R. and Fields R.D. (2011) Control of local protein synthesis and initial events in myelination by action potentials. Science 333, 1647–1651.
Yoshioka A., Hardy M., Younkin D.P., Grinspan J.B., Stern J.L. and Pleasure D. (1995) Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors mediate excitotoxicity in the oligodendroglial lineage. Journal of Neurochemistry 64, 2442–2448.